Sputum Collection and Testing for AFB Using GeneXpert (Xpert MTB/RIF)
For patients suspected of pulmonary tuberculosis, collect at least two sputum specimens for microscopy and one specimen for GeneXpert MTB/RIF testing, with all samples sent for liquid culture; ideally, obtain at least one early morning specimen and initiate testing on the day the patient is identified. 1
Specimen Collection Protocol
Number and Timing of Specimens
- Minimum requirement: At least 2 sputum specimens for microscopy examination and 1 for rapid molecular testing 1
- Optimal approach: Collect 3 sputum samples, as this increases diagnostic yield by 2-3% 1
- Timing: Collect specimens on the same day (not necessarily consecutive days) 1
- Critical specimen: Obtain at least one early morning sample, as this provides higher bacillary yield 1
Quality Requirements
Good quality sputum samples are essential for reliable testing 1. This requires:
- Providing clear, detailed instructions to patients on proper expectoration technique
- Ensuring appropriate collection containers and conditions
- Proper storage and transportation procedures
- Timely processing of specimens 1
When Sputum Cannot Be Obtained
If patients cannot produce sputum spontaneously, use alternative collection methods 1:
- Sputum induction with bronchodilators
- Bronchoscopy/bronchoalveolar lavage (BAL)
- Gastric lavage in children who cannot expectorate 2
GeneXpert MTB/RIF Testing Specifications
Sample Processing
- Direct testing: GeneXpert can be performed directly on untreated sputum without prior decontamination 3
- Processed specimens: When testing concentrated sputum pellets, use a 2:1 sample reagent/pellet ratio rather than the standard 3:1 ratio, as this increases sensitivity, especially in paucibacillary specimens 4
- Turnaround time: Results available in less than 2 hours with minimal hands-on time 3
Performance Characteristics
The GeneXpert MTB/RIF demonstrates 3:
- Smear-positive TB: 98.2% sensitivity
- Smear-negative TB: 72.5% sensitivity with single test; increases to 90.2% with three tests
- Specificity: 99.2%
- Rifampin resistance detection: 97.6% sensitivity and 98.1% specificity
Critical Workflow Points
Initiate testing as early as possible—ideally on the same day the patient is identified 1. This rapid turnaround is crucial for:
- Reducing mortality through early treatment initiation
- Interrupting transmission chains
- Detecting drug resistance immediately
Comprehensive Testing Algorithm
All Specimens Must Undergo:
- Microscopic examination (AFB smear with Ziehl-Neelsen or fluorochrome staining) 1
- GeneXpert MTB/RIF assay for simultaneous TB detection and rifampin resistance 1
- Liquid culture (MGIT system preferred for faster results) 1
- Drug susceptibility testing (DST) on all culture-positive isolates 1
Important Caveat on Molecular Results
Molecular diagnostic results showing rifampin resistance must be confirmed by phenotypic (culture-based) DST 1. In cases of discrepant results, perform sequencing from the isolate to identify mutations 1.
Laboratory Quality Standards
Specimens must be sent to mycobacteriology laboratories that implement 1:
- Optimal laboratory practices per European and international recommendations
- Quality-assured procedures
- WHO-recommended rapid molecular assays
- Proper biosafety protocols
Common Pitfalls to Avoid
Don't use fluoroquinolones during diagnostic workup, as they have anti-TB activity and may cause transient improvement, confusing the diagnosis 1
Don't rely solely on GeneXpert negative results in smear-negative cases—culture remains essential as GeneXpert sensitivity is only 72.5% in smear-negative TB 3, 5
Don't delay specimen collection—obtain samples immediately when TB is suspected, as early diagnosis directly impacts mortality 1
Don't skip culture even when GeneXpert is positive—culture is required for complete DST and monitoring drug resistance trends 1
Ensure proper specimen quality—poorly collected specimens compromise all downstream testing 1